CY1112307T1 - Κυτταροθεραπεια: μεθοδος και συνθεση για θεραπεια διαβητη - Google Patents

Κυτταροθεραπεια: μεθοδος και συνθεση για θεραπεια διαβητη

Info

Publication number
CY1112307T1
CY1112307T1 CY20121100129T CY121100129T CY1112307T1 CY 1112307 T1 CY1112307 T1 CY 1112307T1 CY 20121100129 T CY20121100129 T CY 20121100129T CY 121100129 T CY121100129 T CY 121100129T CY 1112307 T1 CY1112307 T1 CY 1112307T1
Authority
CY
Cyprus
Prior art keywords
composition
cythotherapy
diabetes treatment
pancreases
islet cells
Prior art date
Application number
CY20121100129T
Other languages
English (en)
Inventor
Vladislav Broytman
Nikanor Broytman
Nikolay Skaletskiy
Original Assignee
Philadelphia Medical Scientific Center, L.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philadelphia Medical Scientific Center, L.L.C. filed Critical Philadelphia Medical Scientific Center, L.L.C.
Publication of CY1112307T1 publication Critical patent/CY1112307T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/39—Pancreas; Islets of Langerhans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/02—Atmosphere, e.g. low oxygen conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2523/00—Culture process characterised by temperature

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Μέθοδος λήψης κυττάρων βήτα-νησίδας από παγκρέατα κουνελιών και σύνθεση για μεταμόσχευση (ξενομοσχεύματα ή ξενομεταμοσχεύσεις) κυττάρων βήτα-νησίδας που απομονώνονται και καλλιεργούνται από παγκρέατα κουνελιού για να προάγεται παραγωγή φυσικής ινσουλίνης μεταξύ ανθρώπων με διαβήτη.
CY20121100129T 2006-04-17 2012-02-07 Κυτταροθεραπεια: μεθοδος και συνθεση για θεραπεια διαβητη CY1112307T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79292906P 2006-04-17 2006-04-17
EP07760776A EP2013332B1 (en) 2006-04-17 2007-04-17 Cell therapy: a method and a composition for treating diabetes

Publications (1)

Publication Number Publication Date
CY1112307T1 true CY1112307T1 (el) 2015-12-09

Family

ID=38610440

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20121100129T CY1112307T1 (el) 2006-04-17 2012-02-07 Κυτταροθεραπεια: μεθοδος και συνθεση για θεραπεια διαβητη

Country Status (15)

Country Link
US (2) US9574180B2 (el)
EP (1) EP2013332B1 (el)
AT (1) ATE532526T1 (el)
AU (1) AU2007237934B2 (el)
CA (1) CA2649706C (el)
CY (1) CY1112307T1 (el)
ES (1) ES2377464T3 (el)
HK (1) HK1127086A1 (el)
IL (1) IL194796A (el)
NZ (1) NZ572839A (el)
PL (1) PL2013332T3 (el)
PT (1) PT2013332E (el)
RU (1) RU2450052C2 (el)
WO (1) WO2007121438A2 (el)
ZA (1) ZA200809767B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014151229A1 (en) * 2013-03-15 2014-09-25 Philadelphia Medical Scientific Center, L.L.C. Cell therapy: a method and a composition for treating diabetes
RU2534911C1 (ru) * 2013-10-29 2014-12-10 Сергей Михайлович Чудных Способ лечения сахарного диабета в эксперименте
US20200224165A1 (en) * 2016-07-22 2020-07-16 Senlin Li Methods and compositions for rejuvenation
US11617832B2 (en) 2016-08-17 2023-04-04 International Business Machines Corporation Portal system-based bionic pancreas
KR102060609B1 (ko) 2018-09-13 2019-12-30 사회복지법인 삼성생명공익재단 유도만능줄기세포 유래 내피세포와 요독 복합체를 사용한 요독성 혈관병증 모델 및 이의 이용
WO2023227068A1 (en) * 2022-05-25 2023-11-30 Hangzhou Reprogenix Bioscience, Inc. A new site for transplantation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2069563C1 (ru) * 1993-03-04 1996-11-27 Шилкин Герман Алексеевич Способ лечения диабетической ретинопатии
US5741334A (en) * 1995-06-07 1998-04-21 Circe Biomedical, Inc. Artificial pancreatic perfusion device
RU2135193C1 (ru) * 1997-10-28 1999-08-27 Скалецкий Николай Николаевич Способ получения материала, содержащего бета-клетки поджелудочной железы, для трансплантации больным сахарным диабетом с использованием феномена миграции клеток, материал, содержащий бета-клетки поджелудочной железы, для трансплантации больным сахарным диабетом и способ лечения сахарного диабета методом его трансплантации
US20020071824A1 (en) * 1999-05-27 2002-06-13 Nick Giannoukakis Gene transfer to pancreatic b cells for prevention of islet dysfunction
EP1317253A4 (en) * 2000-07-28 2006-04-26 Univ Emory BIOLOGICAL COMPONENT COMPRISING AN ARTIFICIAL MEMBRANE
US8236771B2 (en) * 2004-05-18 2012-08-07 National Institute Of Transplantation Foundation Vectors and methods for long-term immune evasion to prolong transplant viability

Also Published As

Publication number Publication date
US9574180B2 (en) 2017-02-21
RU2008145053A (ru) 2010-05-27
PL2013332T3 (pl) 2012-04-30
WO2007121438A3 (en) 2008-03-27
PT2013332E (pt) 2012-02-20
AU2007237934A1 (en) 2007-10-25
ES2377464T3 (es) 2012-03-27
US20150284687A1 (en) 2015-10-08
RU2450052C2 (ru) 2012-05-10
IL194796A0 (en) 2009-08-03
NZ572839A (en) 2011-12-22
US20080267925A1 (en) 2008-10-30
WO2007121438A2 (en) 2007-10-25
IL194796A (en) 2014-02-27
EP2013332B1 (en) 2011-11-09
CA2649706C (en) 2013-06-11
EP2013332A2 (en) 2009-01-14
ZA200809767B (en) 2009-11-25
AU2007237934B2 (en) 2012-11-01
EP2013332A4 (en) 2009-05-13
HK1127086A1 (en) 2009-09-18
CA2649706A1 (en) 2007-10-25
ATE532526T1 (de) 2011-11-15

Similar Documents

Publication Publication Date Title
CY1112307T1 (el) Κυτταροθεραπεια: μεθοδος και συνθεση για θεραπεια διαβητη
RU2012105922A (ru) Дифференцирование человеческих эмбриональных стволовых клеток
RU2013110524A (ru) Лечение диабета при помощи панкреатических эндокринных клеток-предшественников
CL2009000782A1 (es) Metodo que comprende un compuesto derivado de oximetilen-arilo sustituido, inhibidores de dpp-iv; y su uso en el tratamiento de la diabetes y disminucion de trigliceridos, entre otras enfermedades.
ATE523585T1 (de) Differenzierung menschlicher embryonaler stammzellen
CR8903A (es) Metodo para la proteccion de plantas utiles o material de propagacion de plantas
ATE500327T1 (de) Verfahren und zusammensetzungen für ethanolproduzierende cyanobakterien
CY1120800T1 (el) Μεθοδοι και συνθεσεις για την in vivo ενεργοποιηση του σχηματισμου παγκρεατικων βητα κυτταρων
EA201071379A1 (ru) Получение бутандиола с помощью анаэробной микробной ферментации
EA201100302A1 (ru) Лечение диабета у пациентов, для которых лечение метформином является неприемлемым
WO2011082038A3 (en) Improved reprogramming compositions
ATE467420T1 (de) Verfahren zur verwendung von guava-extrakt und zusammensetzung mit guava-extrakt
DE502006006107D1 (de) Amid substituierte 8-n-benzimidazole, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CL2011000209A1 (es) Composicion biocida que comprende ciprodinil y piribencarb; metodo para controlar enfermedades en plantas utiles o en material de propagacion causadas por fitopatogenos (div. sol. n° 2602-06).
DK2136619T3 (da) Metode til produktion af mider
AR057058A1 (es) Metodo para usar antagonistas de zonulina para prevenir la perdida o para regenerar celulas pancreaticas
UA109894C2 (uk) Застосування інгібітора сукцинатдегідрогенази в обробці видів рослин сімейства злаки
JP2009516650A5 (el)
NZ598671A (en) Methods for treating irritable bowel syndrome (ibs)
DE502006006241D1 (de) Verwendung von amino substituierten benzimidazolen
IS8646A (is) Aðferð til að framleiða spendýrafrumur
DK2061874T3 (da) Fusionerede mesenchymalstamceller anvendelige til behandling af diabetes og fremgangsmåder hertil
ATE548080T1 (de) Verfahren zur wiederherstellung der erektilen funktion
RU2008106675A (ru) Способ лечения периимплантита
DK2168589T3 (da) Insulinsekretion-inducer og accelerator til forhøjelse af antallet af pankreas-beta-celler